Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001817805 | SCV002069236 | pathogenic | not provided | 2018-08-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004536348 | SCV004755362 | likely pathogenic | UGT1A1-related disorder | 2024-03-05 | no assertion criteria provided | clinical testing | The UGT1A1 c.1381T>C variant is predicted to result in the amino acid substitution p.Trp461Arg. This variant was reported in the homozygous and compound heterozygous states in at least four individuals with Crigler-Najjar syndrome (Maruo et al. 2003. PubMed ID: 14581810; Servedio et al. 2005. PubMed ID: 15712364; Perretti et al. 2007. PubMed ID: 18058623). Functional studies showed that this variant results in no detectable enzyme activity (Maruo et al. 2003. PubMed ID: 14581810). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as likely pathogenic. |